abstract |
The invention described herein includes novel molecules comprising at least one amino acid sequence having significant identity (homology) with human factor VIII and polypeptides or portions thereof that are biologically active, related molecules (such as Nucleic acids encoding such polypeptides), compositions comprising such polypeptides (such as pharmaceutical formulations), and methods of making and using such polypeptides. |